Skip to main content
Erschienen in: Obesity Surgery 11/2020

27.06.2020 | Original Contributions

Laparoscopic Sleeve Gastrectomy Versus Laparoscopic Roux-en-Y Gastric Bypass in Elderly Bariatric Patients: Safety and Efficacy—a Systematic Review and Meta-analysis

verfasst von: Sachin S. Shenoy, Andrew Gilliam, Ahmed Mehanna, Venkatesh Kanakala, Gopinath Bussa, Talvinder Gill, Katherine Sanderson, Y. K. S. Viswanath, Venkatesh Shanmugam

Erschienen in: Obesity Surgery | Ausgabe 11/2020

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Obesity is a chronic disease due to excess fat storage, a genetic predisposition, and environmental contribution where surgery offers a viable treatment option. The surgical treatment of obesity in the elderly population (> 55 years) remains controversial.

Purpose

To evaluate the safety and efficacy of laparoscopic sleeve gastrectomy (LSG) and laparoscopic Roux-en-Y gastric bypass (LRYGB) in elderly bariatric patients.

Materials and Methods

Data was sourced from MEDLINE, EMBASE, CINAHL, PubMed, and Cochrane databases for peer-reviewed, randomized controlled trials, and observational studies in the English language were searched from the year 1991 until 2019. From the extracted data, early and late procedural complications and mortality were used as safety outcomes. Weight loss was the primary outcome for effectiveness while the resolution of obesity-related comorbidities was included as secondary outcomes. The Review Manager (Rev Man 5.3) software was used for statistical analysis.

Results

Of the forty-one screened studies, nine studies were included in the final analysis. There was no difference between LSG and LRYGB regarding early complications and mortality 3.6% versus 5.8% (p = 0.15) and 0.1% versus 0.8% (p = 0.27). Patients who underwent LRYGB had more late complications compared with those who underwent LSG (0.07% and 0.03%, p = 0.001). There was no difference in terms of weight loss at the end of 1 year. Patients who underwent LRYGB had a better resolution of obesity-related comorbidities, not statistically significant.

Conclusion

LRYGB has better efficacy when compared with LSG. However, high-risk elderly patients should be considered for LSG given the lesser morbidity and comparable efficacy with LRYGB.
Literatur
4.
Zurück zum Zitat Pajecki D, Santo M, Joaquim H, et al. Bariatric surgery in the elderly: results of a mean follow up of 5 years. Arq Bras Cir Dig. 2005;28:15–8.CrossRef Pajecki D, Santo M, Joaquim H, et al. Bariatric surgery in the elderly: results of a mean follow up of 5 years. Arq Bras Cir Dig. 2005;28:15–8.CrossRef
6.
Zurück zum Zitat Praveenraj P, Gomes R, Kumar S, et al. Comparison of weight loss outcomes 1 year after sleeve gastrectomy and Roux-en-Y gastric bypass in patients aged above 50 years. J Minim Access Surg. 2016;12:220–5.CrossRefPubMedPubMedCentral Praveenraj P, Gomes R, Kumar S, et al. Comparison of weight loss outcomes 1 year after sleeve gastrectomy and Roux-en-Y gastric bypass in patients aged above 50 years. J Minim Access Surg. 2016;12:220–5.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Huang C, Garg A, Hsin-Chih K, et al. Bariatric surgery in old age: a comparative study of laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy in an Asia centre of excellence. J Biomed Res. 2015;29:118–24.PubMedPubMedCentral Huang C, Garg A, Hsin-Chih K, et al. Bariatric surgery in old age: a comparative study of laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy in an Asia centre of excellence. J Biomed Res. 2015;29:118–24.PubMedPubMedCentral
9.
Zurück zum Zitat Spaniolas K, Trus T, Adrales G, et al. Early morbidity and mortality of laparoscopic sleeve gastrectomy and gastric bypass in the elderly: a NSQIP analysis. Surg Obes Relat Dis. 2010;10:584–8.CrossRef Spaniolas K, Trus T, Adrales G, et al. Early morbidity and mortality of laparoscopic sleeve gastrectomy and gastric bypass in the elderly: a NSQIP analysis. Surg Obes Relat Dis. 2010;10:584–8.CrossRef
10.
Zurück zum Zitat Daigle C, Andalib A, Corcelles R, et al. Bariatric and metabolic outcomes in the super-obese elderly. Surg Obes Relat Dis. 2016;12:132–7.CrossRefPubMed Daigle C, Andalib A, Corcelles R, et al. Bariatric and metabolic outcomes in the super-obese elderly. Surg Obes Relat Dis. 2016;12:132–7.CrossRefPubMed
11.
Zurück zum Zitat Casillas R, Kim B, Fischer H, et al. Comparative effectiveness of sleeve gastrectomy versus Roux-en-Y gastric bypass for weight loss and safety outcomes in older adults. Surg Obes Relat Dis. 2017;13:1476–83.CrossRefPubMed Casillas R, Kim B, Fischer H, et al. Comparative effectiveness of sleeve gastrectomy versus Roux-en-Y gastric bypass for weight loss and safety outcomes in older adults. Surg Obes Relat Dis. 2017;13:1476–83.CrossRefPubMed
12.
Zurück zum Zitat Moon R, Kreimer F, Teixeira A, et al. Morbidity rates and weight loss after Roux-en-Y gastric bypass, sleeve gastrectomy, and adjustable gastric banding in patients older than 60 years old: which procedure to choose? Obes Surg. 2016;26:730–6.CrossRefPubMed Moon R, Kreimer F, Teixeira A, et al. Morbidity rates and weight loss after Roux-en-Y gastric bypass, sleeve gastrectomy, and adjustable gastric banding in patients older than 60 years old: which procedure to choose? Obes Surg. 2016;26:730–6.CrossRefPubMed
13.
Zurück zum Zitat Gray K, Moore M, Bellorin O, et al. Increased metabolic benefit for obese, elderly patients undergoing Roux-en-Y gastric bypass vs sleeve gastrectomy. Obes Surg. 2018;28:636–42.CrossRefPubMed Gray K, Moore M, Bellorin O, et al. Increased metabolic benefit for obese, elderly patients undergoing Roux-en-Y gastric bypass vs sleeve gastrectomy. Obes Surg. 2018;28:636–42.CrossRefPubMed
15.
Zurück zum Zitat Elbahrawy A, Bougie A, Loiselle S, et al. Medium to long-term outcomes of bariatric surgery in older adults with super obesity. Surg Obes Relat Dis. 2018;14:470–6.CrossRefPubMed Elbahrawy A, Bougie A, Loiselle S, et al. Medium to long-term outcomes of bariatric surgery in older adults with super obesity. Surg Obes Relat Dis. 2018;14:470–6.CrossRefPubMed
17.
Zurück zum Zitat Fogarty B, Khan K, Ashall G, et al. Complications of long operations: a prospective study of morbidity associated with prolonged operative time (> 6 h). Br J Plast Surg. 1999;52:32–6.CrossRef Fogarty B, Khan K, Ashall G, et al. Complications of long operations: a prospective study of morbidity associated with prolonged operative time (> 6 h). Br J Plast Surg. 1999;52:32–6.CrossRef
23.
Zurück zum Zitat Gagniere M. Previous gastric banding increases morbidity and gastric leaks after laparoscopic sleeve gastrectomy for obesity. J Visc Surg. 2011;148:205–9.CrossRef Gagniere M. Previous gastric banding increases morbidity and gastric leaks after laparoscopic sleeve gastrectomy for obesity. J Visc Surg. 2011;148:205–9.CrossRef
28.
Zurück zum Zitat Gill R, Birch D, Shi X, et al. Sleeve gastrectomy and type 2 diabetes mellitus: a systematic review. Surg Obes Relat Dis. 2010;6:707–13.CrossRefPubMed Gill R, Birch D, Shi X, et al. Sleeve gastrectomy and type 2 diabetes mellitus: a systematic review. Surg Obes Relat Dis. 2010;6:707–13.CrossRefPubMed
29.
Zurück zum Zitat Knop F, Taylor R. Mechanism of metabolic advantages after bariatric surgery. It’s all gastrointestinal factors versus it’s all food restriction. Diabetes Care. 2013;36:S287–91.CrossRefPubMedPubMedCentral Knop F, Taylor R. Mechanism of metabolic advantages after bariatric surgery. It’s all gastrointestinal factors versus it’s all food restriction. Diabetes Care. 2013;36:S287–91.CrossRefPubMedPubMedCentral
Metadaten
Titel
Laparoscopic Sleeve Gastrectomy Versus Laparoscopic Roux-en-Y Gastric Bypass in Elderly Bariatric Patients: Safety and Efficacy—a Systematic Review and Meta-analysis
verfasst von
Sachin S. Shenoy
Andrew Gilliam
Ahmed Mehanna
Venkatesh Kanakala
Gopinath Bussa
Talvinder Gill
Katherine Sanderson
Y. K. S. Viswanath
Venkatesh Shanmugam
Publikationsdatum
27.06.2020
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 11/2020
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-020-04819-3

Weitere Artikel der Ausgabe 11/2020

Obesity Surgery 11/2020 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.